How Should "CRISPRed" Babies Be Monitored Over Their Life Course to Promote Health Equity?

Charis Thompson1

  • 1A Research Quality Investment Fund professor in the Department of Sociology at the London School of Economics and Political Science in the United Kingdom, and previously a Chancellor's Professor of Gender and Women's Studies at the University of California (UC), Berkeley, where she was also a founding co-director of the Science, Technology, and Society Center.

AMA Journal of Ethics
|December 27, 2019
PubMed

Insights

Future gene-edited children require lifelong health monitoring. Coordinated, anonymized data collection is crucial for safety, efficacy, and equitable access to genomic research and innovation.

Area of Science:

  • Biomedical Ethics
  • Genomic Medicine
  • Public Health

Background:

  • The advent of gene-editing technologies necessitates careful consideration of the long-term implications for individuals born with genetic modifications.
  • Ensuring the well-being of these individuals requires a comprehensive approach to health monitoring and ethical oversight.

Purpose of the Study:

  • To outline a framework for the lifelong monitoring of gene-edited individuals.
  • To address the ethical, social, and research-related challenges associated with human germline gene editing.
  • To propose mechanisms for ensuring responsible innovation and equitable access to gene-editing technologies.

Main Methods:

  • Review of ethical guidelines and existing frameworks for patient monitoring.
  • Analysis of data privacy and anonymization techniques for sensitive genomic information.
  • Exploration of models for international collaboration in health surveillance and research.

Main Results:

  • A proposed model for coordinated, lifelong monitoring of physical, mental, and social health in gene-edited individuals.
  • Emphasis on data anonymization for privacy while enabling aggregate national and international evaluations.
  • Identification of key areas for transnational monitoring: safety, efficacy, social justice, standard of care, and research promotion.

Conclusions:

  • Lifelong, coordinated monitoring is essential for gene-edited individuals.
  • Balancing privacy with the need for aggregate data is critical for safety and research.
  • Development of binding mechanisms to regulate gene-editing technology use is imperative.